First Trust Dow 30 Equal Weight ETF (EDOW)

The First Trust Dow 30 Equal Weight ETF (EDOW) is an exchange-traded fund that tracks a customized version of the Dow Jones Industrial Average, holding all 30 constituent stocks but allocating an equal 3.33% slice of the portfolio to each, regardless of market capitalization.

The equal-weight twist on America’s most famous index

The Dow Jones Industrial Average is a household name — 30 of the largest, most established U.S. companies, from Apple and Microsoft to Coca-Cola and Procter & Gamble. For more than a century it has been treated as a barometer of the American economy and the blue-chip stock market. But the traditional Dow is cap-weighted: the largest companies by market value claim the biggest share of the index, so a move in Apple or Microsoft ripples through the whole thing more loudly than a move in a smaller (though still enormous) blue-chip like Chevron or Caterpillar.

EDOW inverts that logic. It buys all 30 Dow constituents on equal footing. Quarterly, it rebalances each holding back to 3.33% of the portfolio, which means selling winners that have grown above that slice and buying losers that have fallen below it. This is a mechanical form of the investing principle sometimes called “buy low, sell high” — the fund enforces it by calendar, not by conviction.

Why equal weight matters

Cap-weighting, the standard approach, tends to load a portfolio toward recent winners. When a company soars on strong earnings and rises in market value, the Dow’s cap-weighted version automatically gives it more weight, amplifying the gain. Equal weighting resists this drift. By forcing smaller Dow members (in absolute terms — still companies with valuations in the hundreds of billions) back to the same weight as the giants, EDOW tilts the balance toward companies that have underperformed relative to the broader Dow and away from the momentum leaders.

This matters for two reasons. First, it introduces a historical bias toward value — companies trading at lower multiples relative to earnings or dividends often languish in market favour and are smaller by cap within the index, so equal-weighting gives them a structural overweight. Second, it creates a form of disciplined contrarianism: in the quarter after a rally, you are selling Apple and buying Dupont (or whichever Dow name has fallen furthest). Over long periods, this has the potential to improve returns compared to cap-weighting in a mean-reverting market, though there is no guarantee.

What you own and what it costs

EDOW holds all 30 Dow constituents: the technology giants (Apple, Microsoft, Nvidia since 2024), the industrial stalwarts (Caterpillar, Boeing, 3M), the financials (JPMorgan, Goldman Sachs), the staples and healthcare (Coca-Cola, Procter & Gamble, Johnson & Johnson, UnitedHealth), and the energy and materials names that cycle through. Because it is a pure index play — no stock picking, no thematic filtering, just mechanical equal-weighting — it is a transparent and low-cost way to gain Dow exposure with a value tilt.

The fund’s expense ratio is modest (typically under 0.20% per year), which is standard for broad equity ETFs. Liquidity is generally good: EDOW trades millions of shares daily, so bid-ask spreads are tight. Dividends from the 30 constituent stocks (many of which are longtime dividend payers, including several “Dividend Aristocrats” that have raised their payouts for 25+ years) are collected and can be received as cash distributions or reinvested. The quarterly rebalancing incurs some minor trading costs, though First Trust has structured the fund to minimize those frictions.

The risks of equal weighting in practice

Equal-weighting sounds simple and logical, but it carries real constraints. By definition, it forces you to underweight the highest-quality, fastest-growing companies in the Dow (typically the big technologists, which have grown far faster than the old-line industrials). If those companies continue to outperform, the equal-weight approach drags on total return. Conversely, if the market rotates toward value and smaller-cap stocks, equal-weighting can shine.

Concentration is another consideration. EDOW holds just 30 stocks, all large-cap U.S. companies, so it offers no emerging-market exposure, no small-cap diversification, and no international reach. A sustained downturn in large-cap U.S. equities affects the whole portfolio. The quarterly rebalancing also means incurring tax consequences and trading costs, though they are usually small — a cost that shows up in performance relative to a simpler, never-rebalanced cap-weighted version.

Lastly, equal-weighting works best as a long-term bet on mean reversion and undervaluation. In a trending market where winners keep winning, it becomes a drag. Investors using EDOW should expect periods of outperformance and underperformance relative to the traditional market-cap-weighted Dow.

How to evaluate and research EDOW

Any investor considering EDOW should start by understanding the Dow itself — what companies it contains, their sectors and cycles, and why the cap-weighted version behaves as it does. The fund’s prospectus and fact sheet (available from First Trust’s website) spell out the rebalancing mechanics, fees, and tax treatment plainly. Performance comparisons to the cap-weighted Dow Jones Industrial Average Index and to similar broad large-cap funds reveal whether the equal-weight tilt has added or subtracted value over recent years.

A key question to ask yourself: do you believe the next 5–10 years will see mean reversion in the Dow, with lagging names recovering faster than today’s tech giants? If yes, EDOW may be worth a position. If you expect the largest tech firms to continue outpacing the rest, a cap-weighted Dow ETF (like DIA) would likely serve you better. Neither outcome is guaranteed, which is why comparing performance over different time periods and market regimes is essential before committing capital.